|
|
||||||||



* Department of Molecular Pathology, Institute of Pathology, and
Institute of Immunobiology, University of Wuerzburg, Wuerzburg, Germany; and
Department of Immunology, Novartis Research Institute, Vienna, Austria
Treatment of Th cells with compounds that elevate cAMP levels augments Th2-type lymphokine expression, in particular the synthesis of IL-5. Using primary murine CD4+ T lymphocytes, we show in this study that inhibition of protein kinase A (PKA) activity in Th2 effector cells impairs IL-5 synthesis, whereas the expression of PKA catalytic subunit
enhances IL-5 synthesis in Th0 cells. In addition, we observed by coexpression of PKA catalytic subunit and GATA-3 in Th1 cells that the stimulatory effect of PKA is dependent on GATA-3 activity. These data demonstrate that activation of PKA in Th effector cells induces the IL-5 gene expression in a GATA-3-dependent manner.
This article has been cited by other articles:
![]() |
K. Nakano, T. Higashi, R. Takagi, K. Hashimoto, Y. Tanaka, and S. Matsushita Dopamine released by dendritic cells polarizes Th2 differentiation Int. Immunol., June 1, 2009; 21(6): 645 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Liberman, J. Druker, D. Refojo, F. Holsboer, and E. Arzt Glucocorticoids inhibit GATA-3 phosphorylation and activity in T cells FASEB J, May 1, 2009; 23(5): 1558 - 1571. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Klein-Hessling, T. Bopp, M. K. Jha, A. Schmidt, S. Miyatake, E. Schmitt, and E. Serfling Cyclic AMP-induced Chromatin Changes Support the NFATc-mediated Recruitment of GATA-3 to the Interleukin 5 Promoter J. Biol. Chem., November 7, 2008; 283(45): 31030 - 31037. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. C. Liberman, D. Refojo, J. Druker, M. Toscano, T. Rein, F. Holsboer, and E. Arzt The activated glucocorticoid receptor inhibits the transcription factor T-bet by direct protein-protein interaction FASEB J, April 1, 2007; 21(4): 1177 - 1188. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhou, T. S. Blackwell, K. Goleniewska, J. F. O'Neal, G. A. FitzGerald, M. Lucitt, R. M. Breyer, and R. S. Peebles Jr. Prostaglandin I2 analogs inhibit Th1 and Th2 effector cytokine production by CD4 T cells J. Leukoc. Biol., March 1, 2007; 81(3): 809 - 817. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Martucci, S. Franchi, D. Lattuada, A. E. Panerai, and P. Sacerdote Differential involvement of RelB in morphine-induced modulation of chemotaxis, NO, and cytokine production in murine macrophages and lymphocytes J. Leukoc. Biol., January 1, 2007; 81(1): 344 - 354. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Sun, J. Hong, Y. C. Q. Zang, X. Liu, and J. Z. Zhang Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis Int. Immunol., December 1, 2006; 18(12): 1691 - 1700. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. B. Cismasiu, S. Ghanta, J. Duque, D. I. Albu, H.-M. Chen, R. Kasturi, and D. Avram BCL11B participates in the activation of IL2 gene expression in CD4+ T lymphocytes Blood, October 15, 2006; 108(8): 2695 - 2702. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rubenfeld, J. Guo, N. Sookrung, R. Chen, W. Chaicumpa, V. Casolaro, Y. Zhao, V. Natarajan, and S. Georas Lysophosphatidic acid enhances interleukin-13 gene expression and promoter activity in T cells Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L66 - L74. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Roy, J. Wang, R. Charboneau, H. H. Loh, and R. A. Barke Morphine Induces CD4+ T Cell IL-4 Expression through an Adenylyl Cyclase Mechanism Independent of the Protein Kinase A Pathway J. Immunol., November 15, 2005; 175(10): 6361 - 6367. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |